Table 2 Baseline clinical characteristics of adult people living with HIV on ART at Suhul Hospital, Northern Ethiopia, 2010–2014
Characteristic | Number | Percent (%) |
|---|---|---|
Weight | ||
< 50 kg | 126 | 42.7 |
≥ 50 kg | 169 | 57.3 |
Hemoglobin level (g/dl) | ||
< 11 g/dl | 87 | 29.5 |
≥ 11 g/dl | 208 | 70.5 |
CD4 count (cells/mm3) | ||
≤ 200 | 174 | 59.0 |
> 200 | 121 | 41.0 |
WHO clinical stage | ||
I | 95 | 32.2 |
II | 113 | 37.3 |
III | 65 | 22.0 |
IV | 22 | 7.5 |
Functional status | ||
Working | 258 | 87.5 |
Ambulatory | 31 | 10.5 |
Bedridden | 6 | 2.0 |
Opportunistic infections (OIs) | ||
Yes | 88 | 29.8 |
No | 207 | 70.2 |
Tuberculosis disease status | ||
Absent | 269 | 91.2 |
Present | 26 | 8.8 |
Cotrimoxazole prophylactic therapy (CPT) | ||
Yes | 220 | 74.6 |
No | 75 | 25.4 |
Isoniazid prophylactic therapy (IPT) | ||
Yes | 80 | 27.1 |
No | 215 | 72.9 |
Fluconazole prophylactic therapy | ||
Yes | 9 | 3.1 |
No | 286 | 96.9 |
Eligibility criteria for initiating ART | ||
Clinically | 59 | 20.0 |
Immunologically | 157 | 53.4 |
Both | 79 | 26.8 |
Type of ART initiated | ||
AZT-3TC-NVP | 145 | 49.2 |
d4T(30)-3TC-NVP | 109 | 37.0 |
d4T(30)-3TC-EFV | 33 | 11.2 |
d4T(40)-3TC-EFV | 3 | 1.0 |
d4T(40)-3TC-NVP | 5 | 1.7 |
Disclosed HIV serostatus | ||
Yes | 237 | 80.3 |
No | 58 | 19.7 |
HIV serostatus disclosed to (n = 237) | ||
Wife/husband | 140 | 47.5 |
Brother/sister | 41 | 13.9 |
Own children | 39 | 13.2 |
Parent | 4 | 1.4 |
Friends | 13 | 4.4 |